10 results on '"Brenda J. Wilson"'
Search Results
2. Overdiagnosis: causes and consequences in primary health care
- Author
-
Harminder, Singh, James A, Dickinson, Guylène, Thériault, Roland, Grad, Stéphane, Groulx, Brenda J, Wilson, Olga, Szafran, and Neil R, Bell
- Subjects
Physician-Patient Relations ,Practice ,Primary Health Care ,Decision Making ,Humans ,Mass Screening ,Medical Overuse - Published
- 2018
3. Pregnant women’s views on how to promote the use of a decision aid for Down syndrome prenatal screening: a theory-informed qualitative study
- Author
-
Titilayo Tatiana Agbadjé, Matthew Menear, Michèle Dugas, Marie-Pierre Gagnon, Samira Abbasgholizadeh Rahimi, Hubert Robitaille, Anik M. C. Giguère, François Rousseau, Brenda J. Wilson, and France Légaré
- Subjects
Theoretical domains framework ,Health informatics ,Health administration ,0302 clinical medicine ,Behavior Therapy ,Pregnancy ,Prenatal Diagnosis ,Behaviour change techniques ,Decision aids ,Promotion ,Medicine ,030212 general & internal medicine ,Referral and Consultation ,Shared decision making ,Qualitative Research ,030219 obstetrics & reproductive medicine ,lcsh:Public aspects of medicine ,Health Policy ,Nursing research ,Quebec ,Prenatal Care ,Focus Groups ,3. Good health ,Down syndrome prenatal screening ,Female ,Family Practice ,Attitude to Health ,Behaviour change wheel ,Research Article ,Adult ,medicine.medical_specialty ,Decision Making ,Theory of planned behaviour ,Intervention ,Prenatal care ,Decision Support Techniques ,Young Adult ,03 medical and health sciences ,Social support ,Reward ,Humans ,business.industry ,Pregnant women ,Social Support ,lcsh:RA1-1270 ,Focus group ,Patient decision aid ,Family medicine ,Down Syndrome ,business ,Procedures and Techniques Utilization ,Qualitative research - Abstract
Background For pregnant women and their partners, the decision to undergo Down syndrome prenatal screening is difficult. Patient decision aids (PtDA) can help them make an informed decision. We aimed to identify behaviour change techniques (BCTs) that would be useful in an intervention to promote the use of a PtDA for Down syndrome prenatal screening, and to identify which of these BCTs pregnant women found relevant and acceptable. Methods Using the Behaviour Change Wheel and the Theoretical Domains Framework, we conducted a qualitative descriptive study. First, a group of experts from diverse professions, disciplines and backgrounds (eg. medicine, engineering, implementation science, community and public health, shared decision making) identified relevant BCTs. Then we recruited pregnant women consulting for prenatal care in three clinical sites: a family medicine group, a birthing centre (midwives) and a hospital obstetrics department in Quebec City, Canada. To be eligible, participants had to be at least 18 years old, having recently given birth or at least 16 weeks pregnant with a low-risk pregnancy, and have already decided about prenatal screening. We conducted three focus groups and asked questions about the relevance and acceptability of the BCTs. We analysed verbatim transcripts and reduced the BCTs to those the women found most relevant and acceptable. Results Our group of experts identified 25 relevant BCTs relating to information, support, consequences, others’ approval, learning, reward, environmental change and mode of delivery. Fifteen women participated in the study with a mean age of 27 years. Of these, 67% (n = 10) were pregnant for the first time, 20% (n = 3) had difficulty making the decision to take the test, and 73% had made the decision with their partner. Of the 25 BCTs identified using the Behaviour Change Wheel, the women found the following 10 to be most acceptable and relevant: goal setting (behaviour), goal setting (results), problem solving, action plan, social support (general), social support (practical), restructuring the physical environment, prompts/cues, credible sources and modelling or demonstration of the behaviour. Conclusions An intervention to promote PtDA use among pregnant women for Down syndrome prenatal screening should incorporate the 10 BCTs identified.
- Published
- 2018
4. Eliciting patient values and preferences to inform shared decision making in preventive screening
- Author
-
Eddy, Lang, Neil R, Bell, James A, Dickinson, Roland, Grad, Danielle, Kasperavicius, Ainsley Elizabeth, Moore, Harminder, Singh, Guylène, Thériault, Brenda J, Wilson, and Dawn, Stacey
- Subjects
Physician-Patient Relations ,Practice ,Decision Making ,Humans ,Mass Screening ,Patient Preference ,Patient Participation ,Risk Assessment - Published
- 2018
5. Response
- Author
-
Danielle, Kasperavicius, Neil R, Bell, Roland, Grad, James A, Dickinson, Ainsley Elizabeth, Moore, Harminder, Singh, Brett D, Thombs, and Brenda J, Wilson
- Subjects
Research ,Decision Making ,Preventive Health Services ,Mass Screening ,Letters - Published
- 2017
6. Psychosocial Factors of Health Professionals' Intention to Use a Decision Aid for Down Syndrome Screening: Cross-Sectional Quantitative Study
- Author
-
Samira Abbasgholizadeh Rahimi, Johanie Lépine, Jordie Croteau, Hubert Robitaille, Anik MC Giguere, Brenda J Wilson, François Rousseau, Isabelle Lévesque, and France Légaré
- Subjects
Adult ,Down syndrome ,medicine.medical_specialty ,physicians ,Health Personnel ,Decision Making ,Health Informatics ,Prenatal care ,Intention ,03 medical and health sciences ,0302 clinical medicine ,surveys ,Surveys and Questionnaires ,Decision aids ,medicine ,Humans ,030212 general & internal medicine ,midwifery ,Original Paper ,030219 obstetrics & reproductive medicine ,prenatal diagnosis ,decision support techniques ,behavior ,Theory of planned behavior ,Physicians, Family ,Regret ,medicine.disease ,Incentive ,Cross-Sectional Studies ,Evaluation Studies as Topic ,Family medicine ,Female ,Norm (social) ,Psychology ,Psychosocial - Abstract
Background: Decisions about prenatal screening for Down syndrome are difficult for women, as they entail risk, potential loss, and regret. Shared decision making increases women’s knowledge of their choices and better aligns decisions with their values. Patient decision aids foster shared decision making but are rarely used in this context. Objective: One of the most promising strategies for implementing shared decision making is distribution of decision aids by health professionals. We aimed to identify factors influencing their intention to use a DA during prenatal visit for decisions about Down syndrome screening. Methods: We conducted a cross-sectional quantitative study. Using a Web panel, we conducted a theory-based survey of health professionals in Quebec province (Canada). Eligibility criteria were as follows: (1) family physicians, midwives, obstetrician-gynecologists, or trainees in these professions; (2) involved in prenatal care; and (3) working in Quebec province. Participants watched a video depicting a health professional using a decision aid during a prenatal consultation with a woman and her partner, and then answered a questionnaire based on an extended version of the theory of planned behavior, including some of the constructs of the theoretical domains framework. The questionnaire assessed 8 psychosocial constructs (attitude, anticipated regret, subjective norm, self-identity, moral norm, descriptive norm, self-efficacy, and perceived control), 7 related sets of behavioral beliefs (advantages, disadvantages, emotions, sources of encouragement or discouragement, incentives, facilitators, and barriers), and sociodemographic data. We performed descriptive, bivariate, and multiple linear regression analyses to identify factors influencing health professionals’ intention to use a decision aid. Results: Among 330 health professionals who completed the survey, 310 met the inclusion criteria: family physicians, 55.2% (171/310); obstetrician-gynecologists, 33.8% (105/310); and midwives, 11.0% (34/310). Of these, 80.9% were female (251/310). Mean age was 39.6 (SD 11.5) years. Less than half were aware of any decision aids at all. In decreasing order of importance, factors influencing their intention to use a decision aid for Down syndrome prenatal screening were as follows: self-identity (beta=.325, P
- Published
- 2017
7. Health literacy in pregnant women facing prenatal screening may explain their intention to use a patient decision aid: a short report
- Author
-
Agathe Delanoë, Johanie Lépine, Maria Esther Leiva Portocarrero, Hubert Robitaille, Stéphane Turcotte, Isabelle Lévesque, Brenda J. Wilson, Anik M. C. Giguère, and France Légaré
- Subjects
Adult ,Health Knowledge, Attitudes, Practice ,Down syndrome ,Decision Making ,Short Report ,Health literacy ,Prenatal diagnosis ,Intention ,Ambulatory Care Facilities ,General Biochemistry, Genetics and Molecular Biology ,Decision Support Techniques ,Unit (housing) ,03 medical and health sciences ,0302 clinical medicine ,Nursing ,Ambulatory care ,Pregnancy ,Informed consent ,Prenatal Diagnosis ,Surveys and Questionnaires ,medicine ,Decision aids ,Humans ,Screening and diagnostic tests ,030212 general & internal medicine ,Patient involvement ,Shared decision making ,Medicine(all) ,Informed Consent ,Biochemistry, Genetics and Molecular Biology(all) ,business.industry ,030503 health policy & services ,Quebec ,General Medicine ,medicine.disease ,3. Good health ,Patient decision aid ,Prenatal screening ,Female ,Family Practice ,0305 other medical science ,business - Abstract
Background It has been suggested that health literacy may impact the use of decision aids (DAs) among patients facing difficult decisions. Embedded in the pilot test of a questionnaire, this study aimed to measure the association between health literacy and pregnant women’s intention to use a DA to decide about prenatal screening. We recruited a convenience sample of 45 pregnant women in three clinical sites (family practice teaching unit, birthing center and obstetrical ambulatory care clinic). We asked participating women to complete a self-administered questionnaire assessing their intention to use a DA to decide about prenatal screening and assessed their health literacy levels using one subjective and two objective scales. Results Two of the three scales discriminated between levels of health literacy (three numeracy questions and three health literacy questions). We found a positive correlation between pregnant women’s intention to use a DA and subjective health literacy (Spearman coefficient, Rho 0.32, P = 0.04) but not objective health literacy (Spearman coefficient, Rho 0.07, P = 0.65). Hence subjective health literacy may affect the intention to use a DA among pregnant women facing a decision about prenatal screening. Conclusion Special attention should be given to pregnant women with lower health literacy levels to increase their intention to use a DA and ensure that every pregnant women can give informed and value-based consent to prenatal screening. Electronic supplementary material The online version of this article (doi:10.1186/s13104-016-2141-0) contains supplementary material, which is available to authorized users.
- Published
- 2016
8. Decision aids that support decisions about prenatal testing for Down syndrome: an environmental scan
- Author
-
Maria Esther Leiva Portocarrero, Mirjam M Garvelink, Maria Margarita Becerra Perez, Anik Giguère, Hubert Robitaille, Brenda J. Wilson, François Rousseau, and France Légaré
- Subjects
Adult ,medicine.medical_specialty ,Trisomy 21 ,Down syndrome ,Decision Making ,Health Informatics ,Prenatal diagnosis ,Prenatal testing ,Health informatics ,Decision Support Techniques ,Acquired immunodeficiency syndrome (AIDS) ,Pregnancy ,Prenatal Diagnosis ,medicine ,Decision aids ,Humans ,Medical Informatics Applications ,Psychiatry ,Shared decision making ,business.industry ,Health Policy ,medicine.disease ,3. Good health ,Computer Science Applications ,Test (assessment) ,Systematic review ,Decision aid ,Data extraction ,Family medicine ,Female ,business ,Developed country ,Research Article - Abstract
Background Prenatal screening tests for Down syndrome (DS) are routine in many developed countries and new tests are rapidly becoming available. Decisions about prenatal screening are increasingly complex with each successive test, and pregnant women need information about risks and benefits as well as clarity about their values. Decision aids (DAs) can help healthcare providers support women in this decision. Using an environmental scan, we aimed to identify publicly available DAs focusing on prenatal screening/diagnosis for Down syndrome that provide effective support for decision making. Methods Data sources searched were the Decision Aids Library Inventory (DALI) of the Ottawa Patient Decision Aids Research Group at the Ottawa Health Research Institute; Google searches on the internet; professional organizations, academic institutions and other experts in the field; and references in existing systematic reviews on DAs. Eligible DAs targeted pregnant women, focused on prenatal screening and/or diagnosis, applied to tests for fetal abnormalities or aneuploidies, and were in French, English, Spanish or Portuguese. Pairs of reviewers independently identified eligible DAs and extracted characteristics including the presence of practical decision support tools and features to aid comprehension. They then performed quality assessment using the 16 minimum standards established by the International Patient Decision Aids Standards (IPDASi v4.0). Results Of 543 potentially eligible DAs (512 in DALI, 27 from experts, and four on the internet), 23 were eligible and 20 were available for data extraction. DAs were developed from 1996 to 2013 in six countries (UK, USA, Canada, Australia, Sweden, and France). Five DAs were for prenatal screening, three for prenatal diagnosis and 12 for both). Eight contained values clarification methods (personal worksheets). The 20 DAs scored a median of 10/16 (range 6–15) on the 16 IPDAS minimum standards. Discussion None of the 20 included DAs met all 16 IPDAS minimum standards, and few included practical decision support tools or aids to comprehension. Conclusions Our results indicate there is a need for DAs that effectively support decision making regarding prenatal testing for Down syndrome, especially in light of the recently available non-invasive prenatal screening tests. Electronic supplementary material The online version of this article (doi:10.1186/s12911-015-0199-6) contains supplementary material, which is available to authorized users.
- Published
- 2015
9. What factors influence health professionals to use decision aids for Down syndrome prenatal screening?
- Author
-
Johanie Lépine, Maria Esther Leiva Portocarrero, Agathe Delanoë, Hubert Robitaille, Isabelle Lévesque, François Rousseau, Brenda J. Wilson, Anik M. C. Giguère, and France Légaré
- Subjects
Adult ,Male ,medicine.medical_specialty ,Down syndrome ,Health Knowledge, Attitudes, Practice ,Family physicians ,Health Personnel ,Decision Making ,Reproductive medicine ,Prenatal diagnosis ,Context (language use) ,Affect (psychology) ,Midwives ,Decision Support Techniques ,Obstetrician-gynecologists ,03 medical and health sciences ,0302 clinical medicine ,Nursing ,Pregnancy ,Prenatal Diagnosis ,Obstetrics and Gynaecology ,medicine ,Decision aids ,Humans ,Patient decision aids ,030212 general & internal medicine ,Referral and Consultation ,Shared decision making ,Social influence ,Response rate (survey) ,business.industry ,030503 health policy & services ,Obstetrics and Gynecology ,Prenatal screening ,Middle Aged ,medicine.disease ,3. Good health ,Health professionals ,Female ,Theoretical Domains Framework ,0305 other medical science ,business ,Research Article - Abstract
Background Health professionals are expected to engage pregnant women in shared decision making to help them make informed values-based decisions about prenatal screening. Patient decision aids (PtDAs) foster shared decision-making, but are rarely used in this context. Our objective was to identify factors that could influence health professionals to use a PtDA for decisions about prenatal screening for Down syndrome during a clinical pregnancy follow-up. Methods We planned to recruit a purposive sample of 45 health professionals (obstetrician-gynecologists, family physicians and midwives) involved in the care of pregnant women in three clinical sites (15 per site). Participating health professionals first watched a video showing two simulated consecutive prenatal follow-up consultations during which a pregnant woman, her partner and a health professional used a PtDA about Down syndrome prenatal screening. Participants were then interviewed about factors that would influence their use of the PtDA. Questions were based on the Theoretical Domains Framework. We performed content analyses of transcribed verbatim interviews. Results Out of 42 eligible health professionals approached, 36 agreed to be interviewed (86 % response rate). Of these, 27 were female (75 %), nine were obstetrician-gynecologists (25 %), 15 were family physicians (42 %), and 12 were midwives (33 %), with a mean age of 42.1 ± 11.6 years old. We identified 35 distinct factors reported by 20 % or more participants that were mapped onto 10 of the 12 of the Theoretical Domains Framework domains. The six most frequently mentioned factors influencing use of the PtDA were: 1) a positive appraisal (n = 29, 81 %, beliefs about consequences domain); 2) its availability in the office (n = 27, 75 %, environmental context and resources domain); 3) colleagues’ approval (n = 27, 75 %, social influences domain); 4) time constraints (n = 26, 72 %, environmental context and resources domain); 5) finding it a relevant source of information (n = 24, 67 %, motivation and goals domain); and 6) not knowing any PtDAs (n = 23, 64 %, knowledge domain). Conclusions Appraisal, PtDA availability, peer approval, time concerns, evidence and PtDA awareness all affect whether health professionals are likely to use a PtDA to help pregnant women make informed decision about Down syndrome screening. Implementation strategies will need to address these factors. Electronic supplementary material The online version of this article (doi:10.1186/s12884-016-1053-2) contains supplementary material, which is available to authorized users.
- Full Text
- View/download PDF
10. Use of a patient decision aid for prenatal screening for Down syndrome: what do pregnant women say?
- Author
-
Maria Esther Leiva Portocarrero, Anik M. C. Giguère, Johanie Lépine, Mirjam M. Garvelink, Hubert Robitaille, Agathe Delanoë, Isabelle Lévesque, Brenda J. Wilson, François Rousseau, and France Légaré
- Subjects
Adult ,medicine.medical_specialty ,Pediatrics ,Trisomy 21 ,Health Personnel ,Down syndrome ,Decision Making ,Reproductive medicine ,Context (language use) ,Prenatal care ,Prenatal testing ,Theoretical domains framework ,Knowledge translation ,Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18] ,Decision Support Techniques ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,Prenatal Diagnosis ,Obstetrics and Gynaecology ,medicine ,Decision aids ,Humans ,030212 general & internal medicine ,Qualitative Research ,Shared decision making ,Response rate (survey) ,030219 obstetrics & reproductive medicine ,business.industry ,Quebec ,Obstetrics and Gynecology ,medicine.disease ,3. Good health ,Decision aid ,Family medicine ,Implementation ,Female ,Pregnant Women ,business ,Qualitative research ,Research Article - Abstract
Background Patient decision aids (PtDAs) help people make difficult, values-sensitive decisions. Prenatal screening for assessing the risk of genetic conditions in the fetus is one such decision and patient decision aids are rarely used in this clinical context. We sought to identify factors influencing pregnant women’s use of a patient decision aid for deciding about prenatal screening for Down syndrome (DS). Methods This qualitative study was embedded in a sequential mixed-methods research program whose main aim is to implement shared decision-making (SDM) in the context of prenatal screening for DS in the province of Quebec, Canada. We planned to recruit a purposive sample of 45 pregnant women with low-risk pregnancy consulting for prenatal care at three clinical sites. Participating women watched a video depicting a prenatal care follow-up during which a pregnant woman, her partner and a health professional used a PtDA to decide about prenatal screening for DS. The women were then interviewed about factors that would influence the use of this PtDA using questions based on the Theoretical Domains Framework (TDF). We performed content analysis of transcribed verbatim interviews. Results Out of 216 eligible women, 100 agreed to participate (46% response rate) and 46 were interviewed. Regarding the type of health professional responsible for their prenatal care, 19 participants (41%) reported having made a decision about prenatal screening for DS with an obstetrician-gynecologist, 13 (28%) with a midwife, 12 (26%) with a family physician, and two (4%) decided on their own. We identified 54 factors that were mapped onto nine of the 12 TDF domains. The three most frequently-mentioned were: opinion of the pregnant woman’s partner (n = 33, 72%), presentation of the PtDA by health professional and a discussion (n = 27, 72%), and not having encountered a PtDA (n = 26, 57%). Conclusion This study allowed us to identify factors influencing pregnant women’s use of a PtDA for prenatal screening for DS. Use of a PtDA by health professionals and patients is one step in providing the needed decision support and our study results will allow us to design an effective implementation strategy for PtDAs for prenatal screening for DS. Electronic supplementary material The online version of this article (doi:10.1186/s12884-017-1273-0) contains supplementary material, which is available to authorized users.
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.